Dickinson, G. L., Lennard, M. S., Tucker, G. T., & Rostami-Hodjegan, A. (2007). The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example. Blackwell Science Inc.
शिकागो स्टाइल उद्धरणDickinson, Gemma L., Martin S. Lennard, Geoffrey T. Tucker, और Amin Rostami-Hodjegan. The Use of Mechanistic DM-PK-PD Modelling to Assess the Power of Pharmacogenetic Studies –CYP2C9 and Warfarin As an Example. Blackwell Science Inc, 2007.
एमएलए उद्धरणDickinson, Gemma L., Martin S. Lennard, Geoffrey T. Tucker, और Amin Rostami-Hodjegan. The Use of Mechanistic DM-PK-PD Modelling to Assess the Power of Pharmacogenetic Studies –CYP2C9 and Warfarin As an Example. Blackwell Science Inc, 2007.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.